Biotechnology

Septerna's mission is to make the promise of future GPCR medicines a reality for patients.

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingr

Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the dis

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics.

Perricone MD manufactures and sells anti-aging skin care products. It offers skin care treatment products, moisturizers, exfoliators and toners, cleansers, and serums, as well as eye treatment products and products for neck and body. Perricone MD also offers products for deep lines and creases, fine

Next Biosciences is South Africa’s leading biotech company that combines medicine, science and technology enabling people to invest in their future health. Next Biosciences is involved in stem cells, genetics and biologics.

MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

At Mineralys Therapeutics, they aim to redefine hypertension diagnosis, management, and treatment. They are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.

Verily's mission is to make the world’s health data useful so that people enjoy longer and healthier lives. The company was launched in 2015 and is a subsidiary of Alphabet.

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.

The Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths liein diagnostics product development, commercialisation, contract design and manufacturing. The Company’s lead business units

Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future

GRAIL aims to develop a blood test to detect cancer early before symptoms appear offering higher survival rates compared to late-stage diagnosis.

Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.

Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Pierre Fabre Group, also known as Laboratoires Pierre Fabre, operates as a pharmaceutical company in France and internationally.

Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral

Syensqo is a leading science company whose ground-breaking technologies revolutionize the way we live. Our purpose is to advance human progress while cultivating a future for our planet that is not only safer and cleaner, but also inherently more sustainable, driven by the principles of circular eco

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.

PerkinElmer is a global leader focused on improving the health and safety of people and the environment.

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases.

Pharmaron is a research and development service provider for the pharmaceutical industry.

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.

Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines.

Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.

Arine optimizes medications and improves human health through data-driven clinical services.

Akouos is a precision genetic medicine company focused on developing gene therapies with the potential to restore, improve and preserve high-acuity physiologic hearing.

Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness.

Enliven Therapeutics is a biotechnology company focusing on the discovery and development of next generation precision oncology therapeutics.

BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.

KCR is a clinical development solutions provider creating value for biotechnology and pharmaceutical organizations. Founded in 1997, our expert teams support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting, and Placement. KCR operates

Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a

Bavarian Nordic A/S is a biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases.

Alkeus Pharmaceuticals Inc., a Boston-based startup focused on treatments for serious ophthalmic conditions.

Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases.

We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.

Duality Biologics is a company focusing on the discovery, development and commercialization of new modality biologics to provide solutions.

At HealthLytix, we create data analytics solutions to provide comprehensive insights into health status based on genetics and medical imaging. Our products provide consumers with the benefits of early detection and targeted care, while empowering physicians with more accurate diagnostic decision-mak

Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.

We are a Tokyo-based R&D company on a quest to create a new kind of foundation model based on nature-inspired intelligence.

Organovo is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue for medical research and therapeutic applications.

The future doesn’t happen by chance, it’s something we work hard to build. The Technology Innovation Institute (TII) is a pioneering global research institute that focuses on applied research and new-age technology. TII is the applied research pillar of the Advanced Technology Research Council (ATR

Seres Therapeutics is developing revolutionary microbiome-based therapeutics to treat serious diseases.

Bioretec is a Finnish material technology company.

Agilent provides laboratory solutions to meet their full spectrum of needs. They work closely with customers to help address global trends that impact human health and the environment and to anticipate future scientific needs.

Sequity helps labs turn their genomics goals into real, impactful outcomes. We believe microbial genomics should be both accessible and sustainable in every context - and we work shoulder-to-shoulder with you to make that happen.

Neuralink is a team of exceptionally talented people. They are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand their abilities, their community, and their world.